Save your seat

Speaker detail

  • Daniel Tripp
  • Senior Director, Compliance Strategy & Analytics
  • Johnson & Johnson

Daniel Tripp is the Head of Compliance Strategy & Analytics, Consumer & Janssen and is responsible for Pharmacovigilance compliance oversight, training and procedural document development, end of line individual and aggregate report quality and inspection support. Daniel joined Johnson & Johnson after fifteen years at Pfizer Inc. where he served in a variety of positions including most recently as Sr. Director Medical Quality Assurance. In this position Daniel was responsible for quality assurance and auditing activities for the Cardiovascular therapeutic area. Other roles at Pfizer included Director, Inspection Management where he led inspection preparation and management for global Pharmacovigilance and Good Clinical Practice inspections and Director, Quality Safety Alliances where he was responsible for development of a PV CAPA database, a compliance metrics reporting application and oversaw reporting of individual case safety reports to worldwide regulatory authorities and local safety offices. Daniel began his career working at the Autistic Treatment Center in Dallas Texas. He has a Bachelor’s degree in Psychology from the University of North Texas, an MBA from Centenary College and a Six Sigma Black Belt Certificate from Villanova University. He lives in Chester, NJ with his wife Marisa and their three children – Phineas , Dashel and Willow.